Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • budgie lover
    Junior Member
    • Jun 2012
    • 4

    #1

    FPKM values are zero

    Hi everyone,

    When I run Cuffcompare on the merged.gtf I get from Cuffmerge, the FPKM values are zero in the tmap. Does anyone have any idea why this might happen? Running Cuffcompare on individual the individual tissues gives me FPKM values. I did not get an errors in when running anything except when I ran Cuffmerge I got:

    [bam_header_read] EOF marker is absent. The input is probably truncated.
    [bam_header_read] invalid BAM binary header (this is not a BAM file).
    File set_1_merge/tmp/mergeSam_fileHkhL9l doesn't appear to be a valid BAM file, trying SAM...

    But Cuffmerge completed without any errors. I'm not really sure what file Cuffmerge is looking for. Any information on how Cuffmerge works is greatly appreciated.

    Thank you.
  • Chirag
    Member
    • Nov 2011
    • 23

    #2
    I am not exactly sure, but my best guess would be, When you give a reference GTF, while doing cufflinks/cuffmerge, if there are some RNASeq raw reads around those GTF trasncript, it (SEEMS TO) output those transcript.

    To check this: Take those trasncript from "genes.fpkm_tracking" where all FPKM values are 0. Now go these regions and have a look at the raw reads on the browser. You will see (atleast i do in my data) there are some raw reads mapping around those trasncripts, but cufflink is not able to reconstruct the transcript, let alone on it own

    So for now, i extract all those region and exclude them out from the merged.gtf, so i can get the transcript that is actually build on data that we are working.

    This is how i fell, i am not sure, if i am correct !

    cheers
    CN

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    23 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    20 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    36 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    42 views
    0 reactions
    Last Post SEQadmin2  
    Working...